Unlock the White House Watch watch newsletter for free
Your guide on what the US elections of 2024 mean for Washington and Le Monde
President Donald Trump has signed a decree aimed at reducing drug prices for Americans in a decision that would shake the pharmaceutical industry on its largest and profitable market.
The order does not implement the status of “the most favored nation”, which would force manufacturers to drugs to offer their lowest prices in the world in the United States. Trump previously made its doors to other countries to have “Frehing” on American consumers, saying that American patients subsidize cheaper drugs abroad.
But an American official said on Tuesday that the government was “very concentrated on the narrowing of the delta between what the United States price Against what other developed nations do ”.
The United States has paid approximately 3.2 times more for brand medicines than other developed countries in 2022, according to research by Rand Healthcare for the Health and Human Services Department – The most recent data available.
The official said that executive action “would promote a more competitive prescription medication market”.
Trump’s prescription will direct the American drug regulator, the Food and Drug Administration, to allow more states to import drugs directly from countries with lower prices, after Florida authorization in January 2024 to import from Canada.
It also includes modifications to the pricing measures of drugs included in the inflation reduction law of former President Joe Biden, who for the first time allowed Medicare, the public insurance program for the elderly, to negotiate the cost of drugs.
More particularly, the order pushes at the end of the various price negotiation regimes for pills and injectables, which was criticized by the pharmaceutical industry. Under IRA, Medicare could negotiate the price of popular pills after nine years, but should wait 13 until it can negotiate the price of injectables.
But the order does not say how many years the drug manufacturers should wait each category, or explain how they would avoid creating higher costs for health insurance.
During his first mandate, Trump announced a certain number of measures to try to reduce the prices of medicines, in particular to instruct the Secretary of Health and Social Services to test a payment model for a most favored national policy, but this has never been implemented.
The President's order orders the FDA to identify a backlog of generic and biosimular creations by “rationalizing” the approval process. It also reduces the prices of insulin and allergy injectors such as Epipen for unhealthy and low -income.
Monday, the Trump administration launched a national security probe This could lead to prices on pharmaceutical products – and a strong escalation of his trade war – but an American official argued that drug prices could still be reduced.
“We can pursue two things at the same time – by ensuring that government payment and intellectual property) are optimized to provide prices that correspond to the value of a drug, and that we have a secure supply chain in the event of geopolitical conflicts or a natural disaster,” said the manager.
